Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
Travis Mickle(KemPharm (United States)), Lynn R. Webster(Adherent Technologies (United States)), Sven Guenther(KemPharm (United States)), Andrew C. Barrett(KemPharm (United States)), Daniel Dickerson(PRA Health Sciences), Jing Zhou(Worldwide Clinical Trials (United States)), Kathryn Roupe(Worldwide Clinical Trials (United States))
Cited by 7
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain
|Journal of Pain and Symptom Management|2006|304